Professional Overview
Irem F is a seasoned pharmaceutical professional currently serving as a Senior Drug Safety Specialist, bringing expertise in pharmacovigilance and drug safety to the forefront. Her current role and responsibilities encompass ensuring compliance with regulatory requirements, managing drug safety data, and contributing to the development of pharmacovigilance strategies. Key expertise areas include pharmacovigilance, drug safety, and regulatory affairs, with a strong industry focus on pharmaceuticals.
Experience Summary
Current Role
As a Senior Drug Safety Specialist at Eczacıbaşı İlaç Pazarlama, Irem F is responsible for overseeing pharmacovigilance activities, conducting risk assessments, and ensuring the quality of drug safety data. Her key responsibilities include managing adverse event reports, conducting safety reviews, and collaborating with cross-functional teams to develop and implement safety strategies. While specific achievements in this role are not detailed, her position underscores her expertise in pharmacovigilance and commitment to drug safety.
Career Progression
Irem F's career progression is marked by notable roles that have contributed to her growth as a pharmacovigilance specialist. Prior to her current position, she served as a Pharmacovigilance Specialist at Gensenta İlaç from 2019 to 2023, where she would have been involved in similar pharmacovigilance activities, further honing her skills in drug safety and risk management. Earlier in her career, she worked as a Pharmacist at Özge Duacı Eczanesi and completed an internship at GSK, laying the foundation for her future roles in the pharmaceutical industry.
Areas of Expertise
Irem F's areas of expertise include pharmacovigilance, drug safety, regulatory compliance, and risk management. She possesses technical competencies in data analysis, safety reporting, and quality assurance. While specific leadership and management capabilities are not outlined, her senior role suggests proficiency in leading projects or teams related to pharmacovigilance.
Conclusion
Irem F's professional trajectory is characterized by a steady progression in pharmacovigilance and drug safety, with a current focus on senior roles that require in-depth knowledge and expertise. Her value proposition lies in her ability to ensure drug safety, manage pharmacovigilance activities, and contribute to regulatory compliance, making her a valuable asset to pharmaceutical companies.
